These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 20554745)
1. Topical application of valrubicin has a beneficial effect on developing skin tumors. Andersen SM; Rosada C; Dagnaes-Hansen F; Laugesen IG; de Darkó E; Dam TN; Stenderup K Carcinogenesis; 2010 Aug; 31(8):1483-90. PubMed ID: 20554745 [TBL] [Abstract][Full Text] [Related]
2. Valrubicin in a topical formulation treats psoriasis in a xenograft transplantation model. Rosada C; Stenderup K; de Darkó E; Dagnaes-Hansen F; Kamp S; Dam TN J Invest Dermatol; 2010 Feb; 130(2):455-63. PubMed ID: 19741712 [TBL] [Abstract][Full Text] [Related]
3. Valrubicin activates PKCa in keratinocytes: a conceivable mode of action in treating hyper-proliferative skin diseases. Laugesen IG; Hauge E; Andersen SM; Stenderup K; de Darkó E; Dam TN; Rosada C J Drugs Dermatol; 2013 Oct; 12(10):1156-62. PubMed ID: 24085052 [TBL] [Abstract][Full Text] [Related]
4. Topical valrubicin application reduces skin inflammation in murine models. Hauge E; Christiansen H; Rosada C; de Darkó E; Dam TN; Stenderup K Br J Dermatol; 2012 Aug; 167(2):288-95. PubMed ID: 22458650 [TBL] [Abstract][Full Text] [Related]
5. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression. Allen SM; Florell SR; Hanks AN; Alexander A; Diedrich MJ; Altieri DC; Grossman D Cancer Res; 2003 Feb; 63(3):567-72. PubMed ID: 12566297 [TBL] [Abstract][Full Text] [Related]
6. Rationale for intralesional valrubicin in chemoradiation of squamous cell carcinoma of the head and neck. Wani MK; Koseki Y; Yarber RH; Sweatman TW; Ahmed A; Samant S; Hengesteg A; Israel M; Robbins KT Laryngoscope; 2000 Dec; 110(12):2026-32. PubMed ID: 11129014 [TBL] [Abstract][Full Text] [Related]
7. Nexrutine(R) inhibits tumorigenesis in mouse skin and induces apoptotic cell death in human squamous carcinoma A431 and human melanoma A375 cells. Kumar R; Das M; Ansari KM Carcinogenesis; 2012 Oct; 33(10):1909-18. PubMed ID: 22767649 [TBL] [Abstract][Full Text] [Related]
8. Human polymerase alpha inhibitors for skin tumors. Part 2. Modeling, synthesis and influence on normal and transformed keratinocytes of new thymidine and purine derivatives. Höltje M; Richartz A; Zdrazil B; Schwanke A; Dugovic B; Murruzzu C; Reissig HU; Korting HC; Kleuser B; Höltje HD; Schäfer-Korting M J Enzyme Inhib Med Chem; 2010 Apr; 25(2):250-65. PubMed ID: 20222764 [TBL] [Abstract][Full Text] [Related]
9. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis. Puizina-Ivić N; Sapunar D; Marasović D; Mirić L Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009 [TBL] [Abstract][Full Text] [Related]
10. Development of an in vitro model to study carcinogen-induced neoplastic progression of initiated mouse epidermal cells. Morgan D; Welty D; Glick A; Greenhalgh D; Hennings H; Yuspa SH Cancer Res; 1992 Jun; 52(11):3145-56. PubMed ID: 1375535 [TBL] [Abstract][Full Text] [Related]
11. Dual mechanisms of green tea extract (EGCG)-induced cell survival in human epidermal keratinocytes. Chung JH; Han JH; Hwang EJ; Seo JY; Cho KH; Kim KH; Youn JI; Eun HC FASEB J; 2003 Oct; 17(13):1913-5. PubMed ID: 12897059 [TBL] [Abstract][Full Text] [Related]
12. beta-Carotene fails to act as a tumor promoter, induces RAR expression, and prevents carcinoma formation in a two-stage model of skin carcinogenesis in male Sencar mice. Ponnamperuma RM; Shimizu Y; Kirchhof SM; De Luca LM Nutr Cancer; 2000; 37(1):82-8. PubMed ID: 10965524 [TBL] [Abstract][Full Text] [Related]
13. Solanum incanum extract (SR-T100) induces human cutaneous squamous cell carcinoma apoptosis through modulating tumor necrosis factor receptor signaling pathway. Wu CH; Liang CH; Shiu LY; Chang LC; Lin TS; Lan CC; Tsai JC; Wong TW; Wei KJ; Lin TK; Chang NS; Sheu HM J Dermatol Sci; 2011 Aug; 63(2):83-92. PubMed ID: 21612892 [TBL] [Abstract][Full Text] [Related]
14. Altered expression of insulin-like growth factor I and its receptor during multistage carcinogenesis in mouse skin. Rho O; Bol DK; You J; Beltrán L; Rupp T; DiGiovanni J Mol Carcinog; 1996 Oct; 17(2):62-9. PubMed ID: 8890954 [TBL] [Abstract][Full Text] [Related]
15. Honokiol, a phytochemical from the Magnolia plant, inhibits photocarcinogenesis by targeting UVB-induced inflammatory mediators and cell cycle regulators: development of topical formulation. Vaid M; Sharma SD; Katiyar SK Carcinogenesis; 2010 Nov; 31(11):2004-11. PubMed ID: 20823108 [TBL] [Abstract][Full Text] [Related]
16. Chemopreventive effects of sage oil on skin papillomas in mice. Gali-Muhtasib HU; Affara NI Phytomedicine; 2000 Apr; 7(2):129-36. PubMed ID: 10839216 [TBL] [Abstract][Full Text] [Related]
17. Targeted expression of bcl-2 to murine basal epidermal keratinocytes results in paradoxical retardation of ultraviolet- and chemical-induced tumorigenesis. Rossiter H; Beissert S; Mayer C; Schön MP; Wienrich BG; Tschachler E; Kupper TS Cancer Res; 2001 May; 61(9):3619-26. PubMed ID: 11325830 [TBL] [Abstract][Full Text] [Related]
18. Topical sulindac combined with hydrogen peroxide in the treatment of actinic keratoses. Resnick L; Rabinovitz H; Binninger D; Marchetti M; Weissbach H J Drugs Dermatol; 2009 Jan; 8(1):29-32. PubMed ID: 19180893 [TBL] [Abstract][Full Text] [Related]
19. Ultraviolet B radiation regulates cysteine-rich protein 1 in human keratinocytes. Latonen L; Järvinen PM; Suomela S; Moore HM; Saarialho-Kere U; Laiho M Photodermatol Photoimmunol Photomed; 2010 Apr; 26(2):70-7. PubMed ID: 20415737 [TBL] [Abstract][Full Text] [Related]
20. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma. Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]